Minimising the impact of COVID-19 on cancer surgery
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The COVID‐19 pandemic has significantly disrupted cancer treatment nationwide, despite NHS England urging Trusts to ensure cancer care continued. Cautious clinical guidance– avoiding anastomoses, reducing laparoscopy and deferring higher risk patients – coupled with the diversion of resources to manage the expected surge, caused UK cancer surgery numbers to plummet.
British Journal of Surgery , commentaire en libre accès, 2019